We feel now is a pretty good time to analyse Biocept, Inc.'s (NASDAQ:BIOC) business as it appears the company may be on the cusp of a considerable accomplishment. Biocept, Inc., a molecular oncology ...

SAN DIEGO, July 28, 2011 /PRNewswire/ -- Biocept, Inc., an advanced diagnostic CLIA-certified service laboratory developing novel tests for the oncology community, today announced the availability of ...

SAN DIEGO, May 1, 2018 /PRNewswire/ -- Biocept, Inc. (NASDAQ: BIOC), a leading commercial provider of liquid biopsy tests designed to provide physicians with clinically actionable information to ...

The Medical group has plenty of great stocks, but investors should always be looking for companies that are outperforming their peers. Is Biocept, Inc. (BIOC) one of those stocks right now? A quick ...

A Chapter 7 bankruptcy discharge absolves the company from the legal obligation to repay most unsecured debts. Last month, Biocept signed a deal with Plus Therapeutics Inc. Get the data-driven signals ...

SAN DIEGO--(BUSINESS WIRE)--Biocept, Inc. announced today that it has appointed Michael W. Nall as President and Chief Executive Officer. Mr. Nall’s extensive commercialization, sales and marketing ...

SAN DIEGO--(BUSINESS WIRE)--Biocept, Inc. (Nasdaq: BIOC), a leading provider of molecular diagnostic assays, products and services, announces that it will release financial results for the three and ...